Astellas Pharma
4503.T
$9.74
Share price
-0.75%
Change (1 day)
-39.20%
Change (1 year)
Categories
Astellas Pharma (4503.T) - Cash on Hand
Cash on Hand as of December 2023 : $2.02 B
According to Astellas Pharma's latest financial reports the company has $2.02 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Astellas Pharma - Cash on Hand chart (from 2009 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $2.97 B | 7.72% |
| 2022-03-31 | $2.76 B | -8.08% |
| 2021-03-31 | $3.00 B | -0.91% |
| 2020-03-31 | $3.03 B | 7.38% |
| 2019-03-31 | $2.82 B | -12.98% |
| 2018-03-31 | $3.24 B | 2.4% |
| 2017-03-31 | $3.17 B | -4.83% |
| 2016-03-31 | $3.33 B | -12.37% |
| 2015-03-31 | $3.80 B | -8.33% |
| 2014-03-31 | $4.14 B | 23.82% |
| 2013-03-31 | $3.35 B | -7.83% |
| 2012-03-31 | $3.63 B | 70.93% |
| 2011-03-31 | $2.12 B | -62.99% |
| 2010-03-31 | $5.74 B | 10.64% |
| 2009-03-31 | $5.19 B | -4.36% |
| 2008-03-31 | $5.42 B | 17.11% |
| 2007-03-31 | $4.63 B | -14.6% |
| 2006-03-31 | $5.42 B | 33.44% |
| 2005-03-31 | $4.06 B | 18.67% |
| 2004-03-31 | $3.42 B |